[1] O'Flaherty S, Ross RP, Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria[J]. FEMS Microbiol Rev, 2009, 33(4):801-819.[2] 杨文慧, 于龙, 胡凌飞, 等. 分枝杆菌噬菌体D29裂解酶基因的表达与鉴定[J]. 军事医学科学院院刊, 2009, 33(2):113-116.[3] 熊玉霞, 杨致邦, 于拽拽, 等. 分枝杆菌噬菌体D29裂解酶gp10的原核表达及抗脓肿分枝杆菌活性[J]. 中国生物制品学杂志, 2011, 24(11):1269-1272.[4] Bhusal Y, Shiohira CM, Yamane N. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis[J]. Int J Antimicrob Agents, 2005, 26(4):292-297.[5] Campanerut PA, Ghiraldi LD, Spositto FL, et al. Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay[J]. J Antimicrob Chemother, 2011, 66(5):1044-1046.[6] Martin A, Pasch F, Docx S, et al. Multicentre laboratory validation of the colorimetric redox indicator(CRI) assay for the rapid detection of extensively drug-resistant(XDR)Mycobacterium tuberculosis[J]. J Antimicrob Chemother, 2011, 66(4):827-833.[7] Rodriguez-Cerrato V, Garcia P, Del Prado G, et al. In vitro actions of LytA, the major pneumococcal autolysin. With two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic -susceptible and -resistant Streptococcus pneumoniae strains [J]. J Antimicrob Chemother, 2007, 60(5):1159-1162.[8] Drago L, Nicola1 L, Rodighiero V, et al. Comparative evaluation of synergy of combinations of β-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae[J]. J Antimicrob Chemother, 2011, 66(4):845-849.[9] Caleffi-Ferracioli KR, Maltempe FG, Siqueira VL, et al. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method[J]. Tuberculosis, 2013, 93(6):660-663.[10] Fenton M, Ross P, McAuliffe O, et al. Recombinant bacteriophage lysins as antibacterials[J]. Bioeng Bugs, 2010, 1(1):9-16.[11] Lim JA, Shin H, Heu S, et al. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria[J]. J Microbiol Biotechnol, 2014, 24(6):803-811.[12] Lai MJ, Lin NT, Hu A, et al. Antibacterial activity of Acinetobacter baumannii phage ΦAB2 endolysin(LysAB2) against both gram-positive and gram-negative bacteria[J]. Appl Microbiol Biotechnol, 2011, 90(2):529-539.[13] Payne KM, Hatfull GF. Mycobacteriophage endolysins:diverse and modular enzymes with multiple catalytic activities[J]. PLoS One, 2012, 7(3):e34052.[14] Lakshmanan M, Xavier AS. Bedaquiline—The first ATP synthase inhibitor against multidrug resistant tuberculosis[J]. J Young Pharm, 2013, 5(4):112-115.[15] Morbidoni HR, Morbidoni HR. Recycling and refurbishing old antitubercular drugs:the encouraging case of inhibitors of mycolic acid biosynthesis[J]. Expert Rev Anti Infect Ther, 2013, 11(4):429-440.[16] Schuch R, Lee HM, Schneider BC, et al. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia[J]. J Infect Dis, 2014, 209 (9):1469-1478. |